Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louise E Donnelly

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Results and Problems in Cell Differentiation|October 15, 2024
Macrophage Dysfunction in Respiratory DiseaseShyreen Hassibi, Louise E Donnelly
Chest|April 5, 2012
Defective phagocytosis in airways diseaseLouise E Donnelly, Peter J Barnes
International Journal of Chronic Obstructive Pulmonary Disease|August 6, 2021
Leukocyte Function in COPD: Clinical Relevance and Potential for Drug TherapyJonathan R Baker, Louise E Donnelly
American Journal of Respiratory Cell and Molecular Biology|December 26, 2001
Expression and regulation of inducible nitric oxide synthase from human primary airway epithelial cellsLouise E Donnelly, Peter J Barnes
Drugs|September 10, 2003
Therapy for chronic obstructive pulmonary disease in the 21st centuryLouise E Donnelly, Duncan F Rogers
Trends in Pharmacological Sciences|September 24, 2004
Acidic mammalian chitinase--a potential target for asthma therapyLouise E Donnelly, Peter J Barnes
Trends in Pharmacological Sciences|August 17, 2006
Chemokine receptors as therapeutic targets in chronic obstructive pulmonary diseaseLouise E Donnelly, Peter J Barnes
Current Opinion in Pulmonary Medicine|January 18, 2013
Immunopathogenesis of chronic obstructive pulmonary diseaseRebecca A Holloway, Louise E Donnelly
Current Molecular Medicine|August 12, 2008
Th17 cells in airway diseasesSuzanne L Traves, Louise E Donnelly
Pharmacology & Therapeutics|February 17, 2020
Targeting defective pulmonary innate immunity - A new therapeutic option?Kylie B R Belchamber, Louise E Donnelly
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Results and Problems in Cell Differentiation|October 15, 2024
Macrophage Dysfunction in Respiratory DiseaseShyreen Hassibi, Louise E Donnelly
Chest|April 5, 2012
Defective phagocytosis in airways diseaseLouise E Donnelly, Peter J Barnes
International Journal of Chronic Obstructive Pulmonary Disease|August 6, 2021
Leukocyte Function in COPD: Clinical Relevance and Potential for Drug TherapyJonathan R Baker, Louise E Donnelly
American Journal of Respiratory Cell and Molecular Biology|December 26, 2001
Expression and regulation of inducible nitric oxide synthase from human primary airway epithelial cellsLouise E Donnelly, Peter J Barnes
Drugs|September 10, 2003
Therapy for chronic obstructive pulmonary disease in the 21st centuryLouise E Donnelly, Duncan F Rogers
Trends in Pharmacological Sciences|September 24, 2004
Acidic mammalian chitinase--a potential target for asthma therapyLouise E Donnelly, Peter J Barnes
Trends in Pharmacological Sciences|August 17, 2006
Chemokine receptors as therapeutic targets in chronic obstructive pulmonary diseaseLouise E Donnelly, Peter J Barnes
Current Opinion in Pulmonary Medicine|January 18, 2013
Immunopathogenesis of chronic obstructive pulmonary diseaseRebecca A Holloway, Louise E Donnelly
Current Molecular Medicine|August 12, 2008
Th17 cells in airway diseasesSuzanne L Traves, Louise E Donnelly
Pharmacology & Therapeutics|February 17, 2020
Targeting defective pulmonary innate immunity - A new therapeutic option?Kylie B R Belchamber, Louise E Donnelly
Pageof 8